Navigation Links
Pharmasset to Present at Two Upcoming Investor Conferences
Date:3/30/2009

ical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing four product candidates. Clevudine, for the treatment of chronic HBV infection, is enrolling Phase 3 clinical trials for registration in North, Central and South America, Europe, Japan and Taiwan. Clevudine is already approved for HBV in South Korea and the Philippines. It is marketed by Bukwang Pharmaceuticals in South Korea under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, has completed a 4-week clinical trial in combination with Pegasys(R) plus Copegus(R) through a strategic collaboration with Roche. An IND for PSI-7851, a second generation nucleotide HCV inhibitor was filed in January 2009. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.

    Contact
    Richard E. T. Smith, Ph.D.
    VP, Investor Relations and Corporate Communications
    richard.smith@pharmasset.com
    Office: +1 (609) 613-4181

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation, the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the res
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pharmassets Underwriters Release Shares from Lock-Up
2. Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
3. Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
4. Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th
5. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
6. Pharmasset to Webcast an Investor Event from the AASLD Meeting
7. Pharmasset to Present at the 27th Annual JPMorgan Healthcare Conference
8. Pharmasset to Present at Two Upcoming Investor Conferences
9. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
10. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
11. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 As the summer approaches, many people ... It’s important to make safety a top priority, however, and ... tips. , According to the Centers for Disease Control, 10 ... not including boating incidents. Additionally, the National Safety Council says ... 1 to 4. , Amica is sharing the following ...
(Date:5/28/2015)... 2015 ISMETT , a leading transplant ... the Sicilian economy by €132.5 million in expenditure in 2013, ... more than €73 million by retaining patients who otherwise would ... new study by the Battelle Memorial Institute. At the same ... and advanced health care management that is transforming Sicily into ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Altima ... Stencils Device Library for documenting and diagramming data ... Stencils for the following product lines: , ... ASA 5500, Chatsworth Products N-Series TeraFrame Cabinet, Middle ... Corning Eclipse, Fore Systems ForeRunner, Marantz America MM ...
(Date:5/28/2015)... 2015 The CEO and Founder of ... launched blog series which provides analysis on the benefits ... “R. Bruce Dalglish” profile on Blogger.com, this instructive new ... corporate experience. , “Throughout my business career, I’ve ... upon the overall success of businesses,” stated R. Bruce ...
(Date:5/28/2015)... 2015 Senior Housing Assistance Group (SHAG) ... who managed the Seattle Mariners team that won a ... in television and digital advertising for SHAG to help ... including several new communities slated to open in the ... Mountlake Terrace, Tukwila, and University Place. , Filming of ...
Breaking Medicine News(10 mins):Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2Health News:SHAG Announces New Spokesperson: Lou Piniella 2
... of last week,s Congressional hearing into the future of ... for Forensic Odontology Research in the School of Dental ... topic of bitemark analysis. The Congressional hearing focused on ... report on the scientific basis of forensic disciplines. Among ...
... 16 /PRNewswire-FirstCall/ - Attorney Bradley Essman, acting on behalf ... ) has uncovered irregularities in the actions of certain ... stock. , The investigation of these matters is sponsored ... aggressively protect its client companies. Mina Mar is currently ...
... ... of the world,s leading manufacturers of influenza vaccine, announced that the U.S. Food and ... its monovalent pandemic (H1N1) 2009 influenza A vaccine for active immunization of persons age ... ...
... (OTCBB: GVBP.OB) - GENova Biotherapeutics Inc. ("GENova"), a biotechnology ... advance of life-threatening cancers, today announced it has signed ... raising a minimum of USD5m to the company as ... targets. , The deal will entail an upcoming visit ...
... , WINNIPEG, Sept. 16 /PRNewswire/ - In a recent ... of those looking to invest in robotic automation named ... unit for filling IV syringes and bags from Intelligent ... consideration. The survey was conducted in the summer of ...
... Presented by Food & Wine and Travel + Leisure Magazines and ... , NEW YORK, Sept. 16 Food Network ... Schrager is pleased to announce that participating chefs of this year,s Festival ... with Weight Watchers. This is part of Weight Watchers second annual ...
Cached Medicine News:Health News:Bitemark evidence and analysis should be approached with caution, according to UB study 2Health News:Bitemark evidence and analysis should be approached with caution, according to UB study 3Health News:Hard to Treat Diseases, Inc. (HTDS) Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 2Health News:Hard to Treat Diseases, Inc. (HTDS) Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 3Health News:Hard to Treat Diseases, Inc. (HTDS) Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 4Health News:CSL Biotherapies Announces FDA Marketing Approval of its Monovalent Pandemic (H1N1) 2009 Influenza A Vaccine 2Health News:GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited 2Health News:IH Systems RIVA Top Pick for Directors of Pharmacy 2Health News:Chefs Participate in Weight Watchers National Lose For Good(TM) Campaign With 'Chefs Lose For Good' Initiative at the 2009 Food Network New York City Wine & Food Festival 2Health News:Chefs Participate in Weight Watchers National Lose For Good(TM) Campaign With 'Chefs Lose For Good' Initiative at the 2009 Food Network New York City Wine & Food Festival 3Health News:Chefs Participate in Weight Watchers National Lose For Good(TM) Campaign With 'Chefs Lose For Good' Initiative at the 2009 Food Network New York City Wine & Food Festival 4
(Date:5/28/2015)... 2015  Oticon, Inc. is now accepting nominations for ... awards program, now in its 17 th year, ... demonstrate that hearing loss does not limit a person,s ... People with any degree of hearing loss – from ... four categories earn cash prizes, donations to their favorite ...
(Date:5/28/2015)... ALBANY, N.Y. , May 28, 2015 /PRNewswire/ ... "503B Outsourcing Facility" under section 503B of the ... for this title, the company is subject to ... oversight, producing bulk medications according to the highest ... 21 CFR Part 211. To continuously comply with ...
(Date:5/28/2015)... VIEW, Calif. , May 28, 2015 /PRNewswire/ ... informatics market, Frost & Sullivan recognizes Lexmark ... & Sullivan Award for Company of the Year ... to take HCM to the next level of ... strategic acquisitions and followed them up with large-scale ...
Breaking Medicine Technology:2015 Oticon Focus on People Awards Seek Outstanding People with Hearing Loss For National Recognition and Prizes 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5
... LAKE FOREST, Ill., March 5, 2012  RoundTable Healthcare ... exclusively on the healthcare industry, announced today that ... the newly formed RoundTable III Platform Development Corporation ... Mr. Davies will focus his attention on the ...
... 5, 2012   Synteract , Inc., a full-service contract research ... as senior vice president of sales and marketing and has ... global project management, to support growth in the company and ... COO Stewart Bieler, and CFO Patrik Jeanmonod on the executive ...
Cached Medicine Technology:RoundTable Healthcare Partners Names Kent J. Davies CEO of Newly Formed Platform Development Corporation 2Synteract Expands Executive Roles to Support Growth 2Synteract Expands Executive Roles to Support Growth 3
Puntenney curved forceps, curved, smooth 10 mm platforms....
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Curved, very delicate, smooth jaws with platforms., ,Straight, very delicate, smooth jaws with platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Medicine Products: